Bupropion in the tratment of sexual dysfunction in women diagnosed with breast cancer: An open-label, fixed dose study.

@article{Mathias2006BupropionIT,
  title={Bupropion in the tratment of sexual dysfunction in women diagnosed with breast cancer: An open-label, fixed dose study.},
  author={Clarissa Mathias and Emanuela G Moraes and Claudilson Bastos and Rodrigo Abensur Athanazio and Gomez Nunez and L Alban and I Braghirolli and Auro del Giglio and E Pond{\'e} and Harvey Moore},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2006},
  volume={24 18_suppl},
  pages={6072}
}
6072 Background: Sexual morbidity after chemotherapy and hormonal therapy for breast cancer can seriously affect patients' quality of life. Bupropion is an antidepressant that has been reported to increase libido. OBJECTIVE To investigate the improvement of sexual function in female breast cancer patients using bupropion. METHODS We performed an eight… CONTINUE READING